The Evolution of Anti-CD20 Treatment for Multiple Sclerosis: Optimization of Antibody Characteristics and Function.
- Published in:
- CNS Drugs, 2025, v. 39, n. 6, p. 545, doi. 10.1007/s40263-025-01182-8
- By:
- Publication type:
- Article
Works matching IS 11727047 AND DT 2025 AND VI 39 AND IP 6
Results: 7
1
2
Evaluation of Safety, Pharmacokinetic, and Pharmacodynamic Characteristics of a Novel Dual mGluR5/5-HT2AR Antagonist (VVZ-2471) in a Randomized, Double-Blind, First-in-Human Study.
- Published in:
- CNS Drugs, 2025, v. 39, n. 6, p. 583, doi. 10.1007/s40263-025-01181-9
- By:
- Publication type:
- Article
3
Impact of Medical Comorbidities on Ketamine and Esketamine Treatment Effectiveness for Posttraumatic Stress Disorder and Depression: A Clinical Outcomes Analysis from the VA San Diego Healthcare System.
- Published in:
- CNS Drugs, 2025, v. 39, n. 6, p. 609, doi. 10.1007/s40263-025-01180-w
- By:
- Publication type:
- Article
4
Foslevodopa/Foscarbidopa: A Review in Advanced Parkinson's Disease.
- Published in:
- CNS Drugs, 2025, v. 39, n. 6, p. 621, doi. 10.1007/s40263-025-01179-3
- By:
- Publication type:
- Article
5
Opioid Analgesics: Rise and Fall of Ligand Biased Signaling and Future Perspectives in the Quest for the Holy Grail.
- Published in:
- CNS Drugs, 2025, v. 39, n. 6, p. 565, doi. 10.1007/s40263-025-01172-w
- By:
- Publication type:
- Article
6
Clozapine-Related Tachycardia: An Analysis of Incidence.
- Published in:
- CNS Drugs, 2025, v. 39, n. 6, p. 597, doi. 10.1007/s40263-025-01177-5
- By:
- Publication type:
- Article
7
Comparative Efficacy and Safety of Multiple Wake-Promoting Agents for the Treatment of Residual Sleepiness in Obstructive Sleep Apnea Despite Continuous Positive Airway Pressure: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
- Published in:
- CNS Drugs, 2025, v. 39, n. 6, p. 527, doi. 10.1007/s40263-025-01175-7
- By:
- Publication type:
- Article